WIB22: She re­shaped mi­graine sci­ence and led key tri­als for new drugs, but Sheena Au­ro­ra isn’t done

This pro­file is part of End­points News’ 2022 spe­cial re­port about Women in Bio­phar­ma R&D. You can read the full re­port here.

For decades — even cen­turies — mi­graines were con­sid­ered a dis­or­der suf­fered by hys­ter­i­cal women.

Even when the fa­ther of mod­ern-day mi­graine re­search pi­o­neered a new un­der­stand­ing of mi­graine as a bi­o­log­i­cal phe­nom­e­non hav­ing to do with blood ves­sels, he fo­cused on ex­plain­ing the con­di­tion for men but de­scribed women mi­graine suf­fer­ers, who make up the vast ma­jor­i­ty of the pa­tient pop­u­la­tion, as in­ad­e­quate wives and moth­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER